EUVIMEDEUVIMED entdecken
Crossref

Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis

Zhichao Yang, Wenwei Li, Yang Liu, Ming Wei, Zhaoyu Li, Liang Yan, Zezhong Guo, Yang Lv, Feng Li, Wei Zhou, Wei Huang

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Zhichao Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chi…. Hauptthemen laut MEDLINE: Immediate-Early Proteins, Protein Serine-Threonine Kinases, Macrophages, Osteoarthritis. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Anhui Provincial Key Research and Development Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by progressive articular cartilage degradation, synovial inflammation, and pathological fibrosis. Accumulating evidence indicates that synovial pathology-particularly M1 polarization of synovial macrophages and fibrotic remodeling of the synovium-plays a critical role in OA pathogenesis. However, the precise molecular mechanisms governing these processes remain incompletely elucidated. METHODS: In this study, we established a lipopolysaccharide (LPS)-induced M1 macrophage polarization model in RAW264.7 cells and a monosodium iodoacetate (MIA)-induced rat OA model to systematically investigate the role of serum- and glucocorticoid-regulated kinase 1 (SGK1) in OA pathogenesis. RESULTS: Our findings demonstrated that SGK1 expression in synovial tissues from patients with osteoarthritis was significantly and positively correlated with the degree of M1 macrophage polarization. In vitro studies showed that SGK1 gene silencing markedly reduced the secretion of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), in M1-polarized macrophages, and significantly attenuated the migratory and invasive capacities of fibroblast-like synoviocytes (FLS). In the MIA-induced rat osteoarthritis model, intra-articular administration of an SGK1 inhibitor significantly suppressed synovial macrophage M1 polarization and fibrotic remodeling, upregulated the expression of the cartilage-specific extracellular matrix protein type II collagen (COL2A1), and inhibited aberrant matrix metalloproteinase-13 (MMP-13) production. Furthermore, RNA sequencing analysis revealed that SGK1 predominantly regulates macrophage polarization via modulation of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway. CONCLUSION: Collectively, these findings indicate that inhibition of SGK1 suppresses synovial macrophage M1 polarization and attenuates the progression of synovial fibrosis through modulation of the JAK/STAT signaling pathway. These results provide a novel mechanistic rationale and identify SGK1 as a potential therapeutic target for precision treatment of osteoarthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immediate-Early ProteinsProtein Serine-Threonine KinasesMacrophagesOsteoarthritisSynovial MembraneAnimalsSerum-Glucocorticoid Regulated KinasesHumansFibrosisRatsRAW 264.7 CellsMiceMaleRats, Sprague-DawleyCytokines

Stichwörter der Autor:innen

JAK-STAT signalingM1 polarizationOsteoarthritisSGK1Synovial fibrosisTargeted therapy

Substanzen

Serum-Glucocorticoid Regulated KinasesImmediate-Early ProteinsProtein Serine-Threonine KinasesCytokines

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230022, China; Bengbu Medical University, Bengbu 233000, Chi…
  • Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230022, China.
  • Anhui University of Science& Technology, Huainan 232001, China.
  • Anhui Medical University, Hefei 230031, China.
  • Huaibei People's Hospital, Huaibei 235025, China.
  • Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230022, China. Electronic address: zgkdhwei@ustc.edu.cn.

Förderung

  • Anhui Provincial Key Research and Development Plan
  • National Natural Science Foundation of China

Zitieren

APA

Yang, Z., Li, W., Liu, Y., Wei, M., Li, Z., Yan, L., Guo, Z., Lv, Y., Li, F., Zhou, W., & Huang, W. (2026). Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117347

Vancouver

Yang Z, Li W, Liu Y, Wei M, Li Z, Yan L, et al. Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117347

BibTeX
@article{Yang2026,
  author = {Yang, Zhichao and Li, Wenwei and Liu, Yang and Wei, Ming and Li, Zhaoyu and Yan, Liang and Guo, Zezhong and Lv, Yang and Li, Feng and Zhou, Wei and Huang, Wei},
  title = {Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117347}
}
Kostenlos starten →